Effect of dose of behavioral weight loss treatment on glycemic control in adults with prediabetes

Author:

Bauman Viviana,Ariel-Donges Aviva HORCID,Gordon Eliza LORCID,Daniels Michael J,Xu Dandan,Ross Kathryn MORCID,Limacher Marian C,Perri Michael GORCID

Abstract

ObjectiveThis study examined the effects of three doses of behavioral weight loss treatment, compared with a nutrition education control group, on changes in glycemic control in individuals with obesity and prediabetes.Research design and methodsThe study included 287 adults (77% female, 81% White; mean (SD) age=54.1 (10.5) years, body mass index=36.3 (3.9) kg/m2, and hemoglobin A1c (HbA1c)=5.9 (0.2%)). Participants were randomized to one of three behavioral treatment doses (high=24 sessions, moderate=16 sessions, or low=8 sessions) or to an education group (control=8 sessions). Changes in HbA1c, fasting glucose, and body weight were assessed from baseline to 6 months.ResultsMean (99.2% credible interval (CI)) reductions in HbA1c were 0.11% (0.07% to 0.16%), 0.08% (0.03% to 0.13%), 0.03% (–0.01% to 0.07%), and 0.02% (–0.02% to 0.07%), for the high, moderate, low, and control conditions, respectively. Mean (CI) reductions in fasting blood glucose were 0.26 mmol/L (0.14 to 0.39), 0.09 mmol/L (0 to 0.19), 0.01 mmol/L (–0.07 to 0.09), and 0.04 mmol/L (–0.03 to 0.12) for the high, moderate, low, and control conditions, respectively. The high-dose treatment produced significantly greater reductions in HbA1c and fasting blood glucose than the low-dose and control conditions (posterior probabilities (pp)<0.001); no other significant between-group differences were observed. Mean (CI) reductions in body weight were 10.91 kg (9.30 to 12.64), 10.08 kg (8.38 to 11.72), 6.35 kg (5.19 to 7.69), and 3.82 kg (3.04 to 4.54) for the high, moderate, low, and control conditions, respectively. All between-group differences in 6-month weight change were significant (pps<0.001) except for the high-dose versus moderate-dose comparison.ConclusionFor adults with obesity and prediabetes a high dose of behavioral treatment involving 24 sessions over 6 months may be needed to optimize improvements in glycemic control.Trial registration numberNCT00912652.

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

Publisher

BMJ

Subject

Endocrinology, Diabetes and Metabolism

Reference37 articles.

1. Centers for Disease Control and Prevention . National diabetes statistics report, 2017. Available: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html [Accessed 3 April 2019].

2. Prediabetes: a high-risk state for diabetes development

3. Centers for Disease Control and Prevention (CDC). Awareness of prediabetes-United States, 2005-2010;MMWR Morb Mortal Wkly Rep,2013

4. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

5. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3